SML3696
DHMEQ
≥98% (HPLC)
别名:
2-Hydroxy-N-[2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]benzamide, DHM2EQ, Dehydroxymethylepoxyquinomicin, rel-2-Hydroxy-N-[(1R,2R,6R)-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]benzamide
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C13H11NO5
化学文摘社编号:
分子量:
261.23
UNSPSC Code:
12352200
MDL number:
NACRES:
NA.21
InChI
1S/C13H11NO5/c15-8-4-2-1-3-6(8)13(18)14-7-5-9(16)11-12(19-11)10(7)17/h1-5,10-12,15,17H,(H,14,18)/t10-,11+,12-/m0/s1
InChI key
IUOMATKBBPCLFR-TUAOUCFPSA-N
SMILES string
O[C@@H]1[C@@]2([H])[C@](C(C=C1NC(C3=C(C=CC=C3)O)=O)=O)([H])O2
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
Quality Level
Biochem/physiol Actions
Potent, selective, and irreversible inhibitor of NF-κB that covalently binds to a cysteine residue.
DHMEQ is a potent, selective, and irreversible inhibitor of NF-κB that covalently binds to a cysteine residue. It inhibits inflammatory cytokine expression in mice models. DHMEQ is a potent and non/low toxic in vivo anti-inflammatory agent effective in number of animal models.
DHMEQ is a potent, selective, and irreversible inhibitor of NF-κB that covalently binds to a cysteine residue. It inhibits inflammatory cytokine expression in mice models. DHMEQ is a potent and non/low toxic in vivo anti-inflammatory agent effective in number of animal models.
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Reactive oxygen species trigger NF-?B-mediated NLRP3 inflammasome activation involvement in low-dose CdTe QDs exposure-induced hepatotoxicity
Redox Biology, 47, 102157-102157 (2021)
Jun Ma et al.
Cells, 10(9) (2021-09-29)
General inflammatory diseases include skin inflammation, rheumatoid arthritis, inflammatory bowel diseases, sepsis, arteriosclerosis, and asthma. Although these diseases have been extensively studied, most of them are still difficult to treat. Meanwhile, NF-κB is a transcription factor promoting the expression of
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-?B inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat model
BMC Pharmacology & Toxicology, 21(1), 60-60 (2020)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持